DigestRedComo funciona
Red
/
Empresas
Te
No verificado

Tenpoint Therapeutics, Ltd.

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaÓpticaSalud

17 Comunicados de prensa

Ver todos los comunicados de prensa
13/07/2026
Biotecnología
Salud
Farmacéutica
Óptica
Medicina - Varios
Industria
Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0
13/07/2026
Industria
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Óptica
Tenpoint Therapeutics Announces United Kingdom YUVEZZI™ Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0
29/06/2026
Tenpoint Therapeutics Launches YUVEZZI™ Direct-to-Consumer Campaign Featuring a Cast of Hand-Crafted Puppets Giving a Voice to the Everyday Fusses of Blurry Close-Up Vision
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0
07/04/2026
Mercado laboral
Biotecnología
Sanidad
Salud
Farmacéutica
Óptica
Tenpoint Therapeutics, Ltd. Appoints Stephen S. Lane, M.D., as Chief Medical Officer
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0
29/01/2026
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Óptica
Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0
29/01/2026
Multimedia
Salud
Higiene alimentaria
Sanidad
Medicina - Varios
Farmacéutica
Óptica
Biotecnología
Industria
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0
16/12/2025
Eventos
Ciencia
Biotecnología
Farmacéutica
Óptica
Sanidad
Salud
Medicina - Varios
Tenpoint Therapeutics, Ltd. to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0
05/11/2025
Biotecnología
Farmacéutica
Óptica
Salud
Industria
Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia to the MFDS in South Korea
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0
13/10/2025
Asociaciones/Profesionales
Salud
Finanzas
Sanidad
Farmacéutica
Óptica
Biotecnología
Eventos
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0
08/09/2025
Salud
Higiene alimentaria
Ciencia
Farmacéutica
Óptica
Biotecnología
Finanzas
Eventos
Ferias y Congresos
Industria
Tenpoint Therapeutics, Ltd. to Participate in Upcoming Eye Care Conferences
Fuente
Tenpoint Therapeutics, Ltd.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0